These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23910312)

  • 1. Property changes of urinary nanocrystallites and urine of uric acid stone formers after taking potassium citrate.
    Zhang GN; Ouyang JM; Xue JF; Shang YF
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4039-45. PubMed ID: 23910312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake.
    Duan CY; Xia ZY; Zhang GN; Gui BS; Xue JF; Ouyang JM
    Int J Nanomedicine; 2013; 8():909-18. PubMed ID: 23467267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Components of urinary crystallites in urine of uric acid stone formers and its relationship with formation of stones].
    Huang ZJ; Tan J; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Sep; 30(9):2350-4. PubMed ID: 21105393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The property changes of urine crystallites of calcium oxalate stone formers before and after taking medicine].
    Li JJ; Hou SH; Xia ZY; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2011 Aug; 31(8):2263-7. PubMed ID: 22007430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Component analyses of urinary nanocrystallites of uric acid stone formers by combination of high-resolution transmission electron microscopy, fast Fourier transformation, energy dispersive X-ray spectroscopy, X-ray diffraction and Fourier transform infrared spectroscopy.
    Sun XY; Xue JF; Xia ZY; Ouyang JM
    IET Nanobiotechnol; 2015 Jun; 9(3):114-21. PubMed ID: 26023155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
    Grases F; Conte A; March JG; García-Ferragut L; Villalonga N
    Int Urol Nephrol; 1997; 29(3):263-73. PubMed ID: 9285296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on nano- and microcrystallites in the urines of calcium oxalate stone formers].
    Huang ZJ; Li JJ; He JY; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Jul; 30(7):1913-7. PubMed ID: 20827998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
    Soygür T; Akbay A; Küpeli S
    J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites.
    Gao J; Xue JF; Xu M; Gui BS; Wang FX; Ouyang JM
    Int J Nanomedicine; 2014; 9():4399-409. PubMed ID: 25258530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients.
    He JY; Deng SP; Ouyang JM
    IEEE Trans Nanobioscience; 2010 Jun; 9(2):156-63. PubMed ID: 20423812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery.
    Sakhaee K; Griffith C; Pak CY
    Surg Obes Relat Dis; 2012; 8(1):67-72. PubMed ID: 21703942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dietary control for out-patients in urinary stone clinic].
    Kato T; Yanagawa M; Hioki T; Sakurai M; Yamakawa K; Araki T; Yamamoto I; Arima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1993 Jul; 39(7):593-8. PubMed ID: 8362676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.